These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8941630)

  • 1. Hyperuricaemia in renal transplant patients on cyclosporin.
    Marcén R; Gallego N; Teruel JI; Estepa MR; Oreofino L; Ortuño J
    Nephrol Dial Transplant; 1996 Nov; 11(11):2378-80. PubMed ID: 8941630
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.
    Zürcher RM; Bock HA; Thiel G
    Nephrol Dial Transplant; 1996 Jan; 11(1):153-8. PubMed ID: 8649625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients.
    Chanard J; Toupance O; Lavaud S; Hurault de Ligny B; Bernaud C; Moulin B
    Nephrol Dial Transplant; 2003 Oct; 18(10):2147-53. PubMed ID: 13679494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal transplant-associated hyperuricemia and gout.
    Clive DM
    J Am Soc Nephrol; 2000 May; 11(5):974-979. PubMed ID: 10770978
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine-induced hyperuricemia after renal transplant: clinical characteristics and mechanisms.
    Ahn KJ; Kim YS; Lee HC; Park K; Huh KB
    Transplant Proc; 1992 Aug; 24(4):1391-2. PubMed ID: 1496597
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of plasma uric acid on pharmacokinetics of cyclosporine A in living-related renal transplant recipients and pharmacokinetic study in rats with experimental hyperuricaemia.
    Sugioka N; Takai M; Yoshida K; Yasuda K; Fukushima K; Kokuhu T; Okamoto M; Yoshimura N; Takada K
    J Clin Pharm Ther; 2010 Jun; 35(3):323-32. PubMed ID: 20831533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study.
    Zürcher RM; Bock HA; Thiel G
    Nephrol Dial Transplant; 1994; 9(5):548-51. PubMed ID: 8090336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients.
    Cohen SL; Boner G; Rosenfeld JB; Shmueli D; Sperling O; Yusim A; Todd-Pokropek A; Shapira Z
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1829-30. PubMed ID: 3079042
    [No Abstract]   [Full Text] [Related]  

  • 9. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
    Ahmadi F; Naseri R; Lessan-Pezeshki M
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia after kidney transplantation in patients treated with cyclosporine.
    Marcen R; Gallego N; Gamez C; Orofino L; Ortuño J
    Am J Med; 1992 Sep; 93(3):354-5. PubMed ID: 1482484
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete regression of recurrent diffuse malignant lymphoma after withdrawal of cyclosporin A in a renal transplant recipient.
    Kalra PA; Wood GN; O'Donoghue DJ; Mamtora H; Routledge R; Armstrong G; Sinnott PJ; Jos V; Johnson RW; Waldek S
    Nephrol Dial Transplant; 1994; 9(8):1197-200. PubMed ID: 7800229
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M; Hachicha J; Bahloul Z; Kaddour N; Kharrat M; Jarraya F; Jarraya A
    Transplant Proc; 1995 Oct; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
    Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia and gout in renal allograft recipients.
    Delaney V; Sumrani N; Daskalakis P; Hong JH; Sommer BG
    Transplant Proc; 1992 Oct; 24(5):1773-4. PubMed ID: 1412837
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of long-term cyclosporin-A therapy on hematological and biochemical profile in renal transplant patients.
    Islam SI; Ezeamuzie CI; Shaheen FA; Sheikh IA; Masuda QN; Khaleel MH
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):315-21. PubMed ID: 7582381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC
    Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of tubular secretion of urate in renal transplant patients on cyclosporine.
    Marcén R; Gallego N; Orofino L; Gámez C; Estepa MR; Sabater J; Teruel JL; Ortuño J
    Nephron; 1995; 70(3):307-13. PubMed ID: 7477618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quiz page. Stones in the kidney allograft and bladder. Nephrolithiasis is common after transplantation. Cyclosporine often leads to chronic hyperuricemia and the formation of uric acid stones.
    Canas G
    Am J Kidney Dis; 2003 Jan; 41(1):xli. PubMed ID: 12500253
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary capillary leak syndrome associated with the use of intravenous cyclosporin.
    Hussein MM; Mooij JM; el Tayeb AM
    Nephrol Dial Transplant; 1996 Nov; 11(11):2342-3. PubMed ID: 8941609
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperbilirubinemia in a renal transplant patient due to cyclosporin A therapy.
    Ertörer ME; Paydaş S; Sagliker Y
    Nephron; 1997; 76(3):368. PubMed ID: 9226250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.